UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities

Cancer discovery, 2013-07, Vol.3 (7), p.730-741

2013

Volltextzugriff (PDF)

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Cell metabolism, 2006-03, Vol.3 (3), p.187-197

2006

Volltextzugriff (PDF)

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Genes & development, 2012-09, Vol.26 (18), p.2038-2049

2012

Volltextzugriff (PDF)

PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma

Cancer research (Chicago, Ill.), 2016-08, Vol.76 (16), p.4708-4719

2016

Volltextzugriff (PDF)

ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis

Proceedings of the National Academy of Sciences - PNAS, 2015-07, Vol.112 (29), p.9088-9093

2015

Volltextzugriff (PDF)

Mutant IDH is sufficient to initiate enchondromatosis in mice

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (9), p.2829-2834

2015

Volltextzugriff (PDF)

An Alternative Sugar Fuels AML

Cancer cell, 2016-11, Vol.30 (5), p.660-662

2016

Volltextzugriff (PDF)

Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors

BMC cancer, 2017-06, Vol.17 (1), p.418-418, Article 418

2017

Volltextzugriff (PDF)

Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (22), p.9445-9450

2007

Volltextzugriff (PDF)

Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.2054-2061

2004

Volltextzugriff (PDF)

Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

Haematologica (Roma), 2018-03, Vol.103 (3), p.e115

2018

Volltextzugriff (PDF)

Regulation of cancer cell metabolism

Nature reviews. Cancer, 2011-02, Vol.11 (2), p.85

2011

Volltextzugriff (PDF)

Lung Cancer Resets the Liver’s Metabolic Clock

Cell metabolism, 2016-05, Vol.23 (5), p.767-769

2016

Volltextzugriff (PDF)

Drivers of the Warburg phenotype

The cancer journal (Sudbury, Mass.), 2015-03, Vol.21 (2), p.56

Cairns, Rob A

2015

Volltextzugriff (PDF)

Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (5), p.1387-1392

2016

Volltextzugriff (PDF)

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

Blood, 2012-08, Vol.120 (7), p.1466-1469

2012

Volltextzugriff (PDF)

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

Blood, 2012-02, Vol.119 (8), p.1901-1903

2012

Volltextzugriff (PDF)

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (46), p.E10869-E10878

2018

Volltextzugriff (PDF)

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

The Journal of experimental medicine, 2010-02, Vol.207 (2), p.339-344

2010

Volltextzugriff (PDF)

Fire and water: Tumor cell adaptation to metabolic conditions

Experimental cell research, 2017-07, Vol.356 (2), p.204-208

2017

Volltextzugriff (PDF)

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

Proceedings of the National Academy of Sciences - PNAS, 2016-12, Vol.113 (52), p.15084-15089

2016

Volltextzugriff (PDF)

S-2HG is an immunometabolite that shapes the T-cell response

Cell death and differentiation, 2017-02, Vol.24 (2), p.195-196

2017

Volltextzugriff (PDF)

Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma

Cancer research (Chicago, Ill.), 2022-12, Vol.82 (24), p.4695-4695

2022

Volltextzugriff (PDF)

IDH1 deficiency attenuates gluconeogenesis in mouse liver by impairing amino acid utilization

Proceedings of the National Academy of Sciences - PNAS, 2017-01, Vol.114 (2), p.292-297

2017

Volltextzugriff (PDF)

Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML

Leukemia, 2020-04, Vol.34 (4), p.1172-1176

2020

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(90)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma

ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis

Mutant IDH is sufficient to initiate enchondromatosis in mice

An Alternative Sugar Fuels AML

Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors

Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma

Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

Regulation of cancer cell metabolism

Lung Cancer Resets the Liver’s Metabolic Clock

Drivers of the Warburg phenotype

Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Fire and water: Tumor cell adaptation to metabolic conditions

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

S-2HG is an immunometabolite that shapes the T-cell response

Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma

IDH1 deficiency attenuates gluconeogenesis in mouse liver by impairing amino acid utilization

Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML

Suchergebnisse filtern